J
Jin-Mei Jin
Researcher at Shanghai University
Publications - 4
Citations - 190
Jin-Mei Jin is an academic researcher from Shanghai University. The author has contributed to research in topics: Cancer cell & Cancer. The author has an hindex of 3, co-authored 4 publications receiving 101 citations.
Papers
More filters
Journal ArticleDOI
Cardamonin inhibits breast cancer growth by repressing HIF-1α-dependent metabolic reprogramming
Jin-Mei Jin,Shui-Ping Qiu,Ping Wang,Xiaohui Liang,Fei Huang,Hui Wu,Beibei Zhang,Wei-Dong Zhang,Xin-Hui Tian,Ren Xu,Hailian Shi,Xiaojun Wu +11 more
TL;DR: Novel function of cardamonin is revealed in modulating cancer cell metabolism and suppressing breast cancer progression, and its potential for breast cancer treatment is suggested.
Journal ArticleDOI
Astragaloside IV protects blood-brain barrier integrity from LPS-induced disruption via activating Nrf2 antioxidant signaling pathway in mice.
Hong-Li Li,Ping Wang,Fei Huang,Jin-Mei Jin,Hui Wu,Beibei Zhang,Zhifei Wang,Hailian Shi,Xiaojun Wu +8 more
TL;DR: Results demonstrated that ASIV protected the integrity of BBB in LPS‐induced mice, the mechanism of which might be mediated via activating Nrf2 signaling pathway, and suggested that ASiv might be a potential neuroprotective drug acting on BBB.
Journal ArticleDOI
Isoastragaloside I suppresses LPS-induced tight junction disruption and monocyte adhesion on bEnd.3 cells via an activating Nrf2 antioxidant defense system
Hongli Li,Jin-Mei Jin,Chun Yang,Ping Wang,Fei Huang,Hui Wu,Beibei Zhang,Hailian Shi,Xiaojun Wu +8 more
TL;DR: Results indicated that ISOI could protect the integrity of the BBB under inflammatory conditions, which was probably mediated through activating the Nrf2 antioxidant pathway.
Journal ArticleDOI
Helichrysetin inhibits gastric cancer growth by targeting c-Myc/PDHK1 axis-mediated energy metabolism reprogramming.
Ping Wang,Jin-Mei Jin,Xiaohui Liang,Ming-Zhu Yu,Chun Yang,Fei Huang,Hui Wu,Beibei Zhang,Xiaoyan Fei,Zhengtao Wang,Ren Xu,Hailian Shi,Xiaojun Wu +12 more
TL;DR: Results revealed that HEL inhibits gastric cancer growth by targeting mTOR/p70S6K/c-Myc/PDHK1-mediated energy metabolism reprogramming in cancer cells.